Twist, Illumina in partnership to expand access to genetic sequencing panel
JuSun         


Twist Bioscience (NASDAQ:TWST) and Illumina (NASDAQ:ILMN) will partner to expand customer access to theÂ IlluminaÂ Exome 2.0 Plus panelÂ to promote disease research.
Terms call for Twist (TWST) to manufacture the Exome 2.0 Plus panel, which will be sold by Illumina (ILMN) under both companies' brands.
Illumina (ILMN) will offer the panel with its DNA library preparation reagents as a library prep kit and exome enrichment solution for research applications.
Seeking Alpha's Quant Rating views Illumina (ILMN) as a hold with high marks for profitability and momentum.